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Dear Editor, 
 
We would like to thank Dr Arandjelovic [1] for taking the time to read our 
meta-analysis, which statistically synthesized the personal and psychosocial 
predictors of doping use in sport and other physical activity settings. Unfortunately, 
his remarks reveal a misunderstanding regarding the scope of our paper. In essence, 
Dr Arandjelovic charged us with ‘seasoning’ our science with moralistic bias. He then 
presents a number of philosophical questions that, although important and relevant to 
the doping landscape, have nothing to do with our meta-analysis or the studies 
contained within it. This distance between our work and the philosophical challenges 
to anti-doping policy and practice is further underscored by the invitation to engage in 
an intellectual debate on these issues in a sports ethics or medical ethics journal.  
It is worth reiterating that our meta-analysis was not conceived to examine 
current anti-doping policy and practice, nor to present views in favor or against the 
moral aspect of doping/performance enhancing drug use. Our meta-analysis served to 
objectively analyze empirical studies examining doping intentions and doping use in 
order to determine the strongest psychosocial correlates (both positive and negative), 
as well as potential moderator variables. The included empirical studies tested, among 
other predictor variables, morality-related variables such as moral norms and moral 
disengagement, variables that we obviously included in our review. In our discussion, 
and on the basis our results, we (very) briefly state that the findings highlight the 
significance of morality in preventing doping use. Whilst we advocate intellectual 
debate on issues relating to current anti-doping policy and practice, and we are 
cognizant of the arguments in favor of the legalization of doping in sport [2-5], these 
are moot points beyond the scope of our meta-analysis. Further, these articles did not 
test personal or psychological predictors of doping use and, thus, were not included in 
our meta-analysis. 
We are also responding to Dr Arandjelovic because we feel that the readers 
might benefit from reading our views on the issues that he raised in his letter. The 
‘doping is illegal’ heuristic is commonplace in the literature describing doping 
substances and behaviors [6-10]. Inclusion of the term ‘illegal’ in the context of our 
study reflects a dialogical process of interpretation whereby ‘illegal’ relates to the 
intentional breaking of anti-doping rules, through the use of Prohibited substances and 
methods. These rules are constituted and enforced within the sporting context [11].  
To illustrate, an athlete from any country who participates in sport under the authority 
of any signatory of the World Anti-Doping Code (WADC), Government, or other 
sports organisation accepting the Code, found to have administered testosterone 
enanthate without a therapeutic use exemption, would face sanction for committing an 
anti-doping rule violation. Having said this, we are mindful that we might have 
conveyed the view that doping is simply about the use of Prohibited substances and 
methods. To clarify, the World Anti-Doping Agency’s (WADA) definition of doping 
is far more encompassing. Taken directly from the WADC, doping is defined as “the 
occurrence of one or more of the anti-doping rule violations set forth in Article 2.1 
through Article 2.10 of the Code” [12, p.18]. In Article 2.1 a rule violation is the 
“Presence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s 
Sample”. Similarly in Articles 2.2, through to 2.10, rule violations include the use or 
attempted use, possession, trafficking and administration or attempted administration 
of a “Prohibited Substance or Prohibited Method” [12].  
In the context of health and fitness, we agree that the issue of morality is 
questionable and alternative perspectives need to be viewed. In fact, the morality 
variables included in our review were predominantly from competitive sport samples, 
not recreational athletes. Nevertheless, it is interesting to note that the International 
Federation of Bodybuilding and Fitness (IFBB) has accepted the Code and has been 
an official Signatory to the Code since 2003. In its preface to the Anti-Doping Rules 
[13] it states that the adoption and implementation of the Code is in furtherance of the 
“IFBB’s continuing efforts to eradicate doping in the sports it governs” (p.1). The 
IFBB also encourages national associations to incorporate active anti-doping 
programs. 
In some countries (e.g., Denmark), fitness enthusiasts risk social or financial 
sanctions from the National Anti-Doping Organisation (NADO) if they contravene 
anti-doping rules [14].  Whilst many NADO’s do not currently intervene in this way, 
such initiatives appear to be motivated by a desire to promote gyms and fitness 
centers as ‘clean’ exercise environments [15]. It is worth noting that in the 2011 
Communication on Sport [16] it was stated that doping remains “an important threat 
to sport. Use of doping substances by amateur athletes poses serious public health 
hazards and calls for preventive action, including in fitness centers” (p.6). Despite this 
assertion, there are no reliable estimates around the current prevalence of self-directed 
performance and image enhancing drug use in sport and fitness contexts and this 
absence of evidence needs to be addressed.  
We do not disagree with Dr Arandjelovic’s concerns about applying a 
detection-deterrence model in a fitness setting; it will likely be impractical and 
counterproductive. Still, if the threat to public health is real, there is a need to consider 
a preventive framework that incorporates prevention, treatment and after-care [14]. As 
such, we stand by our focus on prevention in the paper, and Dr Arandjevolic’s call for 
a harm-minimization approach would fit within this prevention framework.  
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